Dashboard

Financial News

Avalanche Founder Warns of Bitcoin (BTC) Crisis
headtopics45d ago

Avalanche Founder Warns of Bitcoin (BTC) Crisis

Avalanche founder Emin Gün Sirer warns that Bitcoin's shrinking mining rewards pose a far greater existential threat to the network than quantum computing or competing tokens.

#CRYPTO
Cipher Mining (NASDAQ:CIFR) Price Target Raised to $27.00
americanbankingnews45d ago

Cipher Mining (NASDAQ:CIFR) Price Target Raised to $27.00

Cipher Mining (NASDAQ:CIFR – Free Report) had its target price increased by Keefe, Bruyette & Woods from $23.00 to $27.00 in a report published on Thursday,Benzinga reports. Keefe, Bruyette & Woods currently has an outperform rating on the stock. Several other research firms have also commented on CIFR. Weiss Ratings reissued a “sell (d-)” rating [...]

#CRYPTO
Monness Crespi & Hardt Issues Pessimistic Forecast for Coinbase Global (NASDAQ:COIN) Stock Price
americanbankingnews45d ago

Monness Crespi & Hardt Issues Pessimistic Forecast for Coinbase Global (NASDAQ:COIN) Stock Price

Coinbase Global (NASDAQ:COIN) had its price objective cut by equities researchers at Monness Crespi & Hardt from $115.00 to $110.00 in a research note issued on Friday, MarketBeat Ratings reports. The firm presently has a “neutral” rating on the cryptocurrency exchange’s stock. Monness Crespi & Hardt’s target price points to a potential downside of 45.32% [...]

#CRYPTO
Weekly Pairs In Focus 10Th To 15Th Mayo 2026 (Charts)
menafn45d ago

Weekly Pairs In Focus 10Th To 15Th Mayo 2026 (Charts)

(MENAFN - Daily Forex) GoldThe gold market has initially felt during the week only to turn around and show signs of strength again. The $4,600 level continues to be very important, and I think you ...

#FOREX
Lexicon (LXRX) Reports $21.1M Q1 Revenue Driven by Novo Nordisk Milestones
insidermonkey45d ago

Lexicon (LXRX) Reports $21.1M Q1 Revenue Driven by Novo Nordisk Milestones

​Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) is one of the best fast growing penny stocks to buy right now. On May 7, Lexicon Pharmaceuticals reported Q1 2026 revenue of $21.1 million, a significant increase from $1.3 million in the prior year, driven by $20.0 million in development milestones from its LX9851 partnership with Novo Nordisk. The company [...]

#ECONOMY